Innova Captab (NSE:INNOVACAP) Total Operating Expense: ₹3,840 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INNOVACAP Innova Captab Ltd NSE:INNOVACAP
46 GF Score
Price ₹950.45
! 6 Warning Signs
View Full Analysis

What is Innova Captab Total Operating Expense?

Innova Captab NSE:INNOVACAP -1.81% 46 Total Operating Expense is ₹3,840 Mil as of Mar. 2026. GuruFocus rates NSE:INNOVACAP with a GF Score™ of 46/100. The stock has 6 warning signs investors should review.

Innova Captab's Total Operating Expense for the three months ended in Mar. 2026 was ₹974 Mil. Innova Captab's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3,840 Mil.

Innova Captab Total Operating Expense Related Terms

Innova Captab Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Innova Captab's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innova Captab Total Operating Expense Chart

Innova Captab Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial 846.93 1,191.57 1,849.17 2,309.26 3,356.70

Innova Captab Quarterly Data
Mar19 Mar20 Mar21 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 788.35 897.50 962.61 1,005.03 974.41
NSE:INNOVACAP
46GF Score
Innova Captab Ltd NSE:INNOVACAP
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innova Captab Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,840 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹3,840 Mil mean?
Innova Captab (NSE:INNOVACAP) has a Total Operating Expense of ₹3,840 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Innova Captab and its competitors.
Is Innova Captab's Total Operating Expense too high?
Innova Captab's current Total Operating Expense is ₹3,840 Mil. Overall, Innova Captab has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Innova Captab's Total Operating Expense compare to ZTS?
Innova Captab's Total Operating Expense of ₹3,840 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Innova Captab and its competitors. Innova Captab's current Total Operating Expense is ₹3,840 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innova Captab stock overvalued right now?
Innova Captab (NSE:INNOVACAP) has a current Total Operating Expense of ₹3,840 Mil. The current Total Operating Expense is ₹3,840 Mil. Innova Captab's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Innova Captab (NSE:INNOVACAP), the current Total Operating Expense is ₹3,840 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innova Captab Business Description

Other Exchanges 544067:India
Address Plot No.320, Industrial Area, Phase-1, Panchkula, HR, IND, 134113
Innova Captab Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company has identified "Drugs and pharmaceutical products" as single operating segment. The company has presence in India, and Outside India. The company generates majority of revenue from India. The company's products are Cephalosporins, Proton Pump Inhibitor, Antocholinergic and Heparin NSAIDs, Analgesics and Antipyretic, Anticold and Antiallergic, Antiemetic, Antidiabetic, Antispasmodic, Antifibrinolytic, Cardiovascular, Antioxidant and Vitamins, Antihyperuricemia and Antigout, Fluoroquinolone and Macrolide, Nootropics and Neurotonics/ Neurotrophics, Antiulcerative, Antimalarial Anxiolytic, Anticonvulsant and Antipsychotic, Bladder and Prostate Disorder, etc.
46GF Score

Get the complete analysis for NSE:INNOVACAP

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹950.45
Price